Review Article
Diabetes Medication Management in Patients with Concurrent CKD
Diana Isaacs, Lalita Prasad-Reddy
Correspondence Address :
Dr. Diana Isaacs
Clinical Associate Professor
Chicago State University College of Pharmacy
Chicago
IL, USA
Tel: 773-821-2521
Email: disaacs@csu.edu
Received on: January 22, 2016, Accepted on: February 16, 2016, Published on: February 19, 2016
Citation: Diana Isaacs, Lalita Prasad-Reddy (2016). Diabetes Medication Management in Patients with Concurrent CKD
Copyright: 2016 Diana Isaacs, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Patients with both diabetes and CKD (Chronic Kidney Disease) require a unique clinical approach to therapy. Chronic kidney disease carries an increased risk of morbidity and mortality, and drug dosing is often complicated due to reduced renal clearance and polypharmacy. Patients with diabetes are frequently prescribed multiple medications to reach glucose goals in addition to other therapies that reduce cardiovascular risk, such as aspirin, statins, and antihypertensive medications. Patients with CKD can also present with CKD-related complications like anemia and renal osteodystrophy, further adding to drug therapy. This review highlights the medication management of patients with diabetes that also have concurrent CKD, including the guideline recommendations, the importance of blood pressure and blood glucose goals, and unique challenges in drug selection. The review concludes with the importance of a multidisciplinary approach to the management for the patient with chronic kidney disease.